IMBCR - Institute for Myeloma & Bone Cancer Research Email Format
Research ServicesCalifornia, United States11-50 Employees
IMBCR, the Institute for Myeloma & Bone Cancer Research, is a research organization focused on multiple myeloma and other bone cancers. Based in West Hollywood, California, it pursues approaches to treatment, management, and drug development that prioritize the needs of patients and holistic support. Working with industry leaders and centers of excellence worldwide, IMBCR evaluates existing and novel therapies and investigates unconventional drug combinations to improve outcomes for individuals living with multiple myeloma. The organization operates within the research services industry and engages in collaborations that connect scientific innovation to patient care. In 2019, IMBCR announced a partnership with OncoTracker, Inc. to obtain worldwide rights to IMBCR’s intellectual property covering diagnostic testing and a novel therapeutic approach for treating multiple myeloma.